Exact Mass: 508.0422

Exact Mass Matches: 508.0422

Found 49 metabolites which its exact mass value is equals to given mass value 508.0422, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Griseorhodin A

Griseorhodin A

C25H16O12 (508.0642)


   

6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-4-oxo-4H-chromen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-4-oxo-4H-chromen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20O14 (508.0853)


   

1,4-Dimethoxyglucobrassicin

{[(e)-[2-(1,4-dimethoxy-1H-indol-3-yl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}ethylidene]amino]oxy}sulphonic acid

C18H24N2O11S2 (508.0821)


1,4-Dimethoxyglucobrassicin is found in brassicas. 1,4-Dimethoxyglucobrassicin is isolated from the roots of Barbarea vulgaris ssp. arcuata. Isolated from the roots of Barbarea vulgaris sspecies arcuata. 1,4-Dimethoxyglucobrassicin is found in brassicas.

   

6-{[2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-6-methoxy-4-oxo-4H-chromen-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

6-{[2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-6-methoxy-4-oxo-4H-chromen-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20O14 (508.0853)


   

trans-zeatin riboside diphosphate

{[(3,4-dihydroxy-5-{6-[(4-hydroxy-3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxolan-2-yl)methyl phosphonato]oxy}phosphonic acid

C15H20N5O11P2 (508.0635)


Trans-zeatin riboside diphosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Trans-zeatin riboside diphosphate can be found in a number of food items such as rice, carrot, towel gourd, and chinese bayberry, which makes trans-zeatin riboside diphosphate a potential biomarker for the consumption of these food products.

   

Patuletin 3-glucuronide

Patuletin 3-glucuronide

C22H20O14 (508.0853)


   

Laricitrin 3-glucuronide

Laricitrin 3-glucuronide

C22H20O14 (508.0853)


   

mearnsetin 3-O-beta-D-glucuronide|mearsetin-3-O-beta-glucuronopyranoside

mearnsetin 3-O-beta-D-glucuronide|mearsetin-3-O-beta-glucuronopyranoside

C22H20O14 (508.0853)


   
   
   
   
   
   

CARMINIC ACID

CARMINIC ACID

C22H20O14 (508.0853)


   

1,4-Dimethoxyglucobrassicin

{[(E)-[2-(1,4-dimethoxy-1H-indol-3-yl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino]oxy}sulfonic acid

C18H24N2O11S2 (508.0821)


   

2-Bromo-9,10-bis(2-naphthalenyl)anthracene

2-Bromo-9,10-bis(2-naphthalenyl)anthracene

C34H21Br (508.0827)


   

N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(diethylamino)-4-methoxyphenyl]acetamide

N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(diethylamino)-4-methoxyphenyl]acetamide

C19H21BrN6O6 (508.0706)


   
   

Diphenyl(o-tolyl)phosphine gold(I) chloride

Diphenyl(o-tolyl)phosphine gold(I) chloride

C19H17AuClP (508.0422)


   

1,5-Cyclooctadiene(hexafluoroacetylacetonato)iridium(I)

1,5-Cyclooctadiene(hexafluoroacetylacetonato)iridium(I)

C13H13F6IrO2 (508.0449)


   

disodium 3-[[2-(acetylamino)-4-aminophenyl]azo]naphthalene-1,5-disulphonate

disodium 3-[[2-(acetylamino)-4-aminophenyl]azo]naphthalene-1,5-disulphonate

C18H14N4Na2O7S2 (508.0099)


   

sodium [[3-anilino-9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl]amino]benzenesulphonate

sodium [[3-anilino-9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl]amino]benzenesulphonate

C26H17N2NaO6S (508.0705)


   

TRILITHIUMHEPTAPHOSPHIDE DIMETHOXYETHANE COMPLEX

TRILITHIUMHEPTAPHOSPHIDE DIMETHOXYETHANE COMPLEX

Li3 P7.3 C4 H10 O2 (508.0686)


   

2-Bromo-9,10-di(1-naphthyl)anthracene

2-Bromo-9,10-di(1-naphthyl)anthracene

C34H21Br (508.0827)


   

Linzagolix

Linzagolix

C22H15F3N2O7S (508.0552)


H - Systemic hormonal preparations, excl. sex hormones and insulins > H01 - Pituitary and hypothalamic hormones and analogues > H01C - Hypothalamic hormones > H01CC - Anti-gonadotropin-releasing hormones C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2092 - Gonadotropin Releasing Hormone Antagonist

   

Tivozanib Hydrochloride

Tivozanib Hydrochloride

C22H22Cl2N4O6 (508.0916)


C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

   

mersalyl

mersalyl

C13H17HgNNaO6 (508.066)


C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BC - Mercurial diuretics C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic D004791 - Enzyme Inhibitors

   

6-[2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20O14 (508.0853)


   

9-Ribosyl-trans-zeatin 5-diphosphate(3-)

9-Ribosyl-trans-zeatin 5-diphosphate(3-)

C15H20N5O11P2-3 (508.0635)


   

[[3,4-dihydroxy-5-[6-[[(E)-4-hydroxy-3-methylbut-2-enyl]amino]purin-9-yl]oxolan-2-yl]methoxy-oxidophosphoryl] phosphate

[[3,4-dihydroxy-5-[6-[[(E)-4-hydroxy-3-methylbut-2-enyl]amino]purin-9-yl]oxolan-2-yl]methoxy-oxidophosphoryl] phosphate

C15H20N5O11P2-3 (508.0635)


   

4-amino-N-{(E)-[3-bromo-5-ethoxy-4-(naphthalen-1-ylmethoxy)phenyl]methylidene}-1,2,5-oxadiazole-3-carbohydrazonamide

4-amino-N-{(E)-[3-bromo-5-ethoxy-4-(naphthalen-1-ylmethoxy)phenyl]methylidene}-1,2,5-oxadiazole-3-carbohydrazonamide

C23H21BrN6O3 (508.0858)


   

3-[(5-chloro-2,4-dimethoxyphenyl)-methylsulfamoyl]-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)benzamide

3-[(5-chloro-2,4-dimethoxyphenyl)-methylsulfamoyl]-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)benzamide

C21H21ClN4O5S2 (508.0642)


   

Ethyl 2-[4-[(2,4-dichlorobenzoyl)carbamothioylamino]-3-methylphenyl]-3,3,3-trifluoro-2-hydroxypropanoate

Ethyl 2-[4-[(2,4-dichlorobenzoyl)carbamothioylamino]-3-methylphenyl]-3,3,3-trifluoro-2-hydroxypropanoate

C20H17Cl2F3N2O4S (508.0238)


   
   

N-(4-hydroxy-3-iodo-5-nitrophenylacetyl)-beta-alanylglycylglycine

N-(4-hydroxy-3-iodo-5-nitrophenylacetyl)-beta-alanylglycylglycine

C15H17IN4O8 (508.0091)


   

3,4,5-Trihydroxy-6-[2-methoxy-4-(3,5,6,7-tetrahydroxy-4-oxochromen-2-yl)phenoxy]oxane-2-carboxylic acid

3,4,5-Trihydroxy-6-[2-methoxy-4-(3,5,6,7-tetrahydroxy-4-oxochromen-2-yl)phenoxy]oxane-2-carboxylic acid

C22H20O14 (508.0853)


   

3,4,5-Trihydroxy-6-[5,6,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-3-yl]oxyoxane-2-carboxylic acid

3,4,5-Trihydroxy-6-[5,6,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-3-yl]oxyoxane-2-carboxylic acid

C22H20O14 (508.0853)


   

9-Ribosyl-trans-zeatin 5-diphosphate(3-)

9-Ribosyl-trans-zeatin 5-diphosphate(3-)

C15H20N5O11P2 (508.0635)


A organophosphate oxoanion that is ADP(3-) substituted at position N-6 by a (2E)-4-hydroxy-3-methylbut-2-en-1-yl group; major structure at pH 7.3.

   

PD0325901-O-C2-dioxolane

PD0325901-O-C2-dioxolane

C18H16F3IN2O4 (508.0107)


PD0325901-O-C2-dioxolane has main portion of MEK inhibitor PD0325901. PD0325901-O-C2-dioxolane and a ligand of VHL or CRBN E3 ligase can be used in the synthesis of MEK1/2 degrader[1].

   

(2s,3s,4s,5r,6s)-6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6s)-6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20O14 (508.0853)


   

(2s)-4,9,10'-trihydroxy-7-methoxy-5,8,9'-trioxo-3',4'-dihydro-3h-spiro[naphtho[2,3-b]furan-2,2'-pyrano[3,2-g]isochromene]-7'-carboxylic acid

(2s)-4,9,10'-trihydroxy-7-methoxy-5,8,9'-trioxo-3',4'-dihydro-3h-spiro[naphtho[2,3-b]furan-2,2'-pyrano[3,2-g]isochromene]-7'-carboxylic acid

C25H16O12 (508.0642)


   

1-[3-(acetyloxy)-5-[(3-bromopropa-1,2-dien-1-yl)oxy]oxolan-2-yl]-3-bromooct-5-en-2-yl acetate

1-[3-(acetyloxy)-5-[(3-bromopropa-1,2-dien-1-yl)oxy]oxolan-2-yl]-3-bromooct-5-en-2-yl acetate

C19H26Br2O6 (508.0096)


   

{[2-(1,4-dimethoxyindol-3-yl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino}oxysulfonic acid

{[2-(1,4-dimethoxyindol-3-yl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino}oxysulfonic acid

C18H24N2O11S2 (508.0821)


   

(2s,3s,5e)-1-[(2r,3r,5r)-3-(acetyloxy)-5-[(3-bromopropa-1,2-dien-1-yl)oxy]oxolan-2-yl]-3-bromooct-5-en-2-yl acetate

(2s,3s,5e)-1-[(2r,3r,5r)-3-(acetyloxy)-5-[(3-bromopropa-1,2-dien-1-yl)oxy]oxolan-2-yl]-3-bromooct-5-en-2-yl acetate

C19H26Br2O6 (508.0096)


   

4,9,10'-trihydroxy-7-methoxy-5,8,9'-trioxo-3',4'-dihydro-3h-spiro[naphtho[2,3-b]furan-2,2'-pyrano[3,2-g]isochromene]-7'-carboxylic acid

4,9,10'-trihydroxy-7-methoxy-5,8,9'-trioxo-3',4'-dihydro-3h-spiro[naphtho[2,3-b]furan-2,2'-pyrano[3,2-g]isochromene]-7'-carboxylic acid

C25H16O12 (508.0642)


   

(2s,3s,4s,5r,6s)-6-{[2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6s)-6-{[2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20O14 (508.0853)


   

(2s)-5,8,10'-trihydroxy-7-methoxy-4,9,9'-trioxo-3',4'-dihydro-3h-spiro[naphtho[2,3-b]furan-2,2'-pyrano[3,2-g]isochromene]-7'-carboxylic acid

(2s)-5,8,10'-trihydroxy-7-methoxy-4,9,9'-trioxo-3',4'-dihydro-3h-spiro[naphtho[2,3-b]furan-2,2'-pyrano[3,2-g]isochromene]-7'-carboxylic acid

C25H16O12 (508.0642)


   

[(z)-[2-(1,4-dimethoxyindol-3-yl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino]oxysulfonic acid

[(z)-[2-(1,4-dimethoxyindol-3-yl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino]oxysulfonic acid

C18H24N2O11S2 (508.0821)


   

6-{[2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

6-{[2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20O14 (508.0853)